Find Anidulafungin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

50RELATED EXCIPIENT COMPANIES

109EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Eraxis, 166663-25-8, Ecalta, V-echinocandin, Ver-002, Ly303366
Molecular Formula
C58H73N7O17
Molecular Weight
1140.2  g/mol
InChI Key
JHVAMHSQVVQIOT-MFAJLEFUSA-N
FDA UNII
9HLM53094I

Anidulafungin
Echinocandin antifungal agent that is used in the treatment of CANDIDEMIA and CANDIDIASIS.
Anidulafungin is an Echinocandin Antifungal.
1 2D Structure

Anidulafungin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide
2.1.2 InChI
InChI=1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1
2.1.3 InChI Key
JHVAMHSQVVQIOT-MFAJLEFUSA-N
2.1.4 Canonical SMILES
CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O
2.1.5 Isomeric SMILES
CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O
2.2 Other Identifiers
2.2.1 UNII
9HLM53094I
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-((4r,5r)-4,5-dihydroxy-n2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-l-ornithine)-echinocandin B

2. Eraxis

3. Ly 303366

4. Ly-303366

5. Ly303366

2.3.2 Depositor-Supplied Synonyms

1. Eraxis

2. 166663-25-8

3. Ecalta

4. V-echinocandin

5. Ver-002

6. Ly303366

7. Ly-303366

8. Anidulafungin (ly303366)

9. Ver002

10. Chebi:55346

11. 9hlm53094i

12. D70013

13. D-70013

14. N-[(3s,6s,9s,11r,15s,18s,20r,21r,24s,25s,26s)-6-[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1r)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide

15. Anidulafungin [usan]

16. Anidulafungina

17. Anidulafungine

18. Anidulafunginum

19. Unii-9hlm53094i

20. Anidulafungin [usan:inn:ban]

21. Anidulafungin [mi]

22. Anidulafungin [inn]

23. Schembl38292

24. Anidulafungin [vandf]

25. (4r,5r)-4,5-dihydroxy-n(sup 2)-((4'-(pentyloxy)-p-terphenyl-4-yl)carbonyl)-l-ornithyl-l-threonyl-trans-4-hydroxy-l-prolyl-(s)-4-hydroxy-4-(p-hydroxyphenyl)-l-threonyl-l-threonyl-(3s,4s)-3-hydroxy-4-methyl-l-proline Cyclic (6-1)-peptide

26. Anidulafungin [mart.]

27. Anidulafungin [who-dd]

28. Chembl264241

29. Anidulafungin [ema Epar]

30. Anidulafungin [orange Book]

31. Bdbm50417554

32. Mfcd00917070

33. S4286

34. Ccg-270647

35. Cs-1824

36. Db00362

37. Ncgc00386349-01

38. Hy-13553

39. Sw222238-1

40. A13436

41. 663a258

42. J-010304

43. Q4764531

44. (4r,5r)-4,5-dihydroxy-n(sup 2)-((4''-(pentyloxy)-p-terphenyl-4-yl)carbonyl)-l-ornithyl-l-threonyl-trans-4-hydroxy-l-prolyl-(s)-4-hydroxy-4-(p-hydroxyphenyl)-l-threonyl-l-threonyl-(3s,4s)-3-hydroxy-4-methyl-l-proline Cyclic (6->1)-peptide

45. Echinocandin B, 1-((4r,5r)-4,5-dihydroxy-n(sup 2)-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-l-ornithine)-

46. Echinocandin B, 1-((4r,5r)-4,5-dihydroxy-n2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-l-ornithine)

47. N-[(3s,6s,9s,11r,15s,18s,20r,21r,24s,25s,26s)-6-[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1r)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-4-{4-[4-(pentyloxy)phenyl]phenyl}benzamide

48. N-[[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-tetrahydroxy-bis[(1r)-1-hydroxyethyl]-methyl-hexaoxo-[?]yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide

49. N-{(2r,6s,9s,11r,12r,14as,15s,16s,20s,23s,25as)-23-[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6,20-bis[(1r)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1h-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-4''-(pentyloxy)-1,1':4',1''-terphenyl-4-carboxamide

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 1140.2 g/mol
Molecular Formula C58H73N7O17
XLogP32.3
Hydrogen Bond Donor Count14
Hydrogen Bond Acceptor Count17
Rotatable Bond Count14
Exact Mass1139.50629389 g/mol
Monoisotopic Mass1139.50629389 g/mol
Topological Polar Surface Area377 Ų
Heavy Atom Count82
Formal Charge0
Complexity2150
Isotope Atom Count0
Defined Atom Stereocenter Count15
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameEraxis
PubMed HealthAnidulafungin (Injection)
Drug ClassesAntifungal
Drug LabelERAXIS for Injection is a sterile, lyophilized product for intravenous (IV) infusion that contains anidulafungin. ERAXIS (anidulafungin) is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is...
Active IngredientAnidulafungin
Dosage FormInjectable
Routeinjection; Iv (infusion)
Strength100mg/vial; 50mg; 50mg/vial
Market StatusPrescription
CompanyPfizer; Vicuron

2 of 2  
Drug NameEraxis
PubMed HealthAnidulafungin (Injection)
Drug ClassesAntifungal
Drug LabelERAXIS for Injection is a sterile, lyophilized product for intravenous (IV) infusion that contains anidulafungin. ERAXIS (anidulafungin) is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is...
Active IngredientAnidulafungin
Dosage FormInjectable
Routeinjection; Iv (infusion)
Strength100mg/vial; 50mg; 50mg/vial
Market StatusPrescription
CompanyPfizer; Vicuron

4.2 Drug Indication

For use in the treatment of the following fungal infections: Candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis), Aspergillus infections, and esophageal candidiasis. Also considered an alternative treatment for oropharyngeal canaidiasis.


FDA Label


Treatment of invasive candidiasis in adults and paediatric patients aged 1 month to < 18 years.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Anidulafungin is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is an echinocandin, a class of antifungal drugs that inhibits the synthesis of 1,3-β-D-glucan, an essential component of fungal cell walls. Anidulafungin is active in vitro against many Candida, as well as some Aspergillus. Like other echinocandins, anidulafungin is not active against Cryptococcus neoformans, Trichosporon, Fusarium, or zygomycetes.


5.2 MeSH Pharmacological Classification

Antifungal Agents

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ANIDULAFUNGIN
5.3.2 FDA UNII
9HLM53094I
5.3.3 Pharmacological Classes
Lipopeptides [CS]; Echinocandin Antifungal [EPC]
5.4 ATC Code

J02AX06


J - Antiinfectives for systemic use

J02 - Antimycotics for systemic use

J02A - Antimycotics for systemic use

J02AX - Other antimycotics for systemic use

J02AX06 - Anidulafungin


5.5 Absorption, Distribution and Excretion

Route of Elimination

Less than 1% of the administered radioactive dose was excreted in the urine. Anidulafungin is not hepatically metabolized.


Volume of Distribution

30 to 50 L


Clearance

1 L/h


5.6 Metabolism/Metabolites

Hepatic metabolism of anidulafungin has not been observed. Anidulafungin is not a clinically relevant substrate, inducer, or inhibitor of cytochrome P450 (CYP450) isoenzymes. Anidulafungin undergoes slow chemical degradation at physiologic temperature and pH to a ring-opened peptide that lacks antifungal activity.


5.7 Biological Half-Life

40-50 hours


5.8 Mechanism of Action

Anidulafungin is a semi-synthetic echinocandin with antifungal activity. Anidulafungin inhibits glucan synthase, an enzyme present in fungal, but not mammalian cells. This results in inhibition of the formation of 1,3-β-D-glucan, an essential component of the fungal cell wall, ultimately leading to osmotic instability and cell death.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648146600,"product":"ANIDULAFUNGIN BATCH NO-BM21004987","address":"20TH K M, HOSUR ROAD,,ELECTRONIC C ITY P.O,","city":"BANGALORE,KARNATAKA","supplier":"BIOCON LTD","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"UNDISCLOSED","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"8","unit":"GMS","unitRateFc":"210","totalValueFC":"1285.8","currency":"USD","unitRateINR":12250,"date":"25-Mar-2022","totalValueINR":"98000","totalValueInUsd":"1285.8","indian_port":"BANGALORE AIR","hs_no":"29181990","bill_no":"9218627","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"20TH K M, HOSUR ROAD,,ELECTRONIC C ITY P.O,, BANGALORE,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702665000,"product":"PHARMACEUTICAL RAW MATERIAL- ANIDULAFUNGIN IH (B.NO.ANI\/23\/001 M.DT. OCT, 2023,RETEST DT- SEP, 2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"SUAN FARMA MEXICO S A DE CV","customerCountry":"MEXICO","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"165","totalValueFC":"16313.7","currency":"USD","unitRateINR":13580,"date":"16-Dec-2023","totalValueINR":"1358000","totalValueInUsd":"16313.7","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"6084010","productDescription":"API","marketType":"","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704911400,"product":"PHARMACEUTICAL RAW MATERIAL- ANIDULAFUNGIN IH BATCH NO. - ANI\/23\/001 MFG. DATE -OCT, 2023 RETEST DATE - SEP, 2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"DEMO S A","customerCountry":"GREECE","quantity":"0.13","actualQuantity":"133","unit":"GMS","unitRateFc":"210","totalValueFC":"27575.9","currency":"USD","unitRateINR":17232.180451127821,"date":"11-Jan-2024","totalValueINR":"2291880","totalValueInUsd":"27575.9","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"6689519","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"ANIDULAFUNGIN IH (BATCH NO: - ANI\/25\/001 MFG DATE :- JAN,2025 RE-TEST DATE :- DEC,2027)","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ATH?NAI","customer":"UNDISCLOSED","customerCountry":"GREECE","quantity":"0.25","actualQuantity":"250","unit":"GMS","unitRateFc":"210","totalValueFC":"52185","currency":"USD","unitRateINR":18152.900000000001,"date":"14-Feb-2025","totalValueINR":"4538225","totalValueInUsd":"52185","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"8165256","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689100200,"product":"ANIDULAFUNGIN","address":"Ashvich Towers 3rd Floor, No 3, Developed Plots In","city":"Chennai","supplier":"SHENZHEN SIJIA PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"CAPLIN POINT LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.99","actualQuantity":"0.99","unit":"KGS","unitRateFc":"140000","totalValueFC":"140388.3","currency":"USD","unitRateINR":"11655000.3","date":"12-Jul-2023","totalValueINR":"11538450.27","totalValueInUsd":"140388.3","indian_port":"MADRAS AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Ashvich Towers 3rd Floor, No 3, Developed Plots In"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692383400,"product":"ANIDULAFUNGIN","address":"NARBHAVI,NO 3 LAKSHMANAN STREET T NAGAR","city":"CHENNAI","supplier":"SHENZHEN SIJIA PHARMACEUTICALS CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"CAPLIN POINT LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.59","actualQuantity":"0.59","unit":"KGS","unitRateFc":"140000","totalValueFC":"83493.3","currency":"USD","unitRateINR":"11605282.9","date":"19-Aug-2023","totalValueINR":"6916279.72","totalValueInUsd":"83493.3","indian_port":"CHENNAI AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NARBHAVI,NO 3 LAKSHMANAN STREET T NAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694802600,"product":"ANIDULAFUNGIN","address":"NARBAVI, NO.3,LAKSHMANAN STREET,","city":"CHENNAI\/TAMILNADU","supplier":"SHENZHEN SIJIA PHARMACEUTICALS CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"CAPLIN POINT LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.70","actualQuantity":"0.7","unit":"KGS","unitRateFc":"135000","totalValueFC":"95572.2","currency":"USD","unitRateINR":"11333250","date":"16-Sep-2023","totalValueINR":"7933275","totalValueInUsd":"95572.2","indian_port":"Madras Air","hs_no":"29420090","bill_no":"7867663","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"B305,HUIZHONG MINGYUAN,NO.99DENGLIANG ROAD,NANSHAN DISTRICTSHENZHEN CITY, CHINA 518052 CN","customerAddress":"NARBAVI, NO.3,LAKSHMANAN STREET,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702578600,"product":"ANIDULAFUNGIN","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"BRIGHTGENE BIO MEDICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"JODAS EXPOIM PRIVATE LTD","customerCountry":"INDIA","quantity":"0.08","actualQuantity":"0.08","unit":"KGS","unitRateFc":"150000","totalValueFC":"12152.4","currency":"USD","unitRateINR":"12645000","date":"15-Dec-2023","totalValueINR":"1011600","totalValueInUsd":"12152.4","indian_port":"Hyderabad Air","hs_no":"29419090","bill_no":"9242875","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"TECHNOLOGY CO LTD BUILDING C25-C28NO.218 XINGHU ROAD, SUZHOU INDUSTRIAL PARK China","customerAddress":"101, SITARAM MANSION,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710441000,"product":"ANIDULAFUNGIN","address":"NARBAVI, NO.3,LAKSHMANAN STREET,","city":"CHENNAI\/TAMILNADU","supplier":"RELIABLE PHARMATECH TANJIN CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"CAPLIN POINT LABORATORIES LTD","customerCountry":"INDIA","quantity":"1.20","actualQuantity":"1.2","unit":"KGS","unitRateFc":"135000","totalValueFC":"163393.4","currency":"USD","unitRateINR":"11306250","date":"15-Mar-2024","totalValueINR":"13567500","totalValueInUsd":"163393.4","indian_port":"Madras Air","hs_no":"29420090","bill_no":"2588453","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"ZUOANMINGDI XIANSHUIGU JINNANDISTRICT TIANJIN300350 CN","customerAddress":"NARBAVI, NO.3,LAKSHMANAN STREET,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718994600,"product":"ANIDULAFUNGIN","address":"Galaxy, Floors 22-24, Plot No. 1, Survey No. 83\/1","city":"HYDERABAD","supplier":"BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"EUGIA STERILES PRIVATE LTD","customerCountry":"INDIA","quantity":"1.71","actualQuantity":"1.707","unit":"KGS","unitRateFc":"230000","totalValueFC":"396469.2","currency":"USD","unitRateINR":"19389000","date":"22-Jun-2024","totalValueINR":"33097023","totalValueInUsd":"396469.2","indian_port":"Hyderabad Air","hs_no":"29419090","bill_no":"4124363","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"CORPORATE ADDRESS: BUILDING C25-28,NO. 218 XINGHU ROAD, SUZHOU INDUSTRIAL PARK, SUZHOU, JIANGSU, CHINA China","customerAddress":"Galaxy, Floors 22-24, Plot No. 1, Survey No. 83\/1"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"ANIDULAFUNGIN","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"JODAS EXPOIM PRIVATE LTD","customerCountry":"INDIA","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"150000","totalValueFC":"7571.5","currency":"USD","unitRateINR":"12690000","date":"30-Sep-2024","totalValueINR":"634500","totalValueInUsd":"7571.5","indian_port":"Hyderabad Air","hs_no":"29419090","bill_no":"5875048","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"BUILDING C25-C28 NO.218 XINGHU ROAD ,SUZHOU INDDUSTRIAL PARK SDNF China","customerAddress":"101, SITARAM MANSION,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"ANIDULAFUNGIN ANIDULAFUNGIN","address":"NARBAVI, NO.3,LAKSHMANAN STREET,","city":"CHENNAI\/TAMILNADU","supplier":"HANGZHOU PROSERRE CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"CAPLIN POINT LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.006","unit":"KGS","unitRateFc":"133333.3","totalValueFC":"803.6","currency":"USD","unitRateINR":"11380000","date":"02-Dec-2024","totalValueINR":"68280","totalValueInUsd":"803.6","indian_port":"Madras Air","hs_no":"29420090","bill_no":"6994893","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"ROOM 2002 SUNON CENTRAL MANSION NO 200 SHIMIN ROAD, JIANGGAN DISTRICT, HANGZHOU ZHEJIANG CN","customerAddress":"NARBAVI, NO.3,LAKSHMANAN STREET,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1751826600,"product":"ANIDULAFUNGIN ANIDULAFUNGIN","address":"NARBAVI, NO.3,LAKSHMANAN STREET,","city":"CHENNAI\/TAMILNADU","supplier":"RELIABLE PHARMATECH TANJIN CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"CAPLIN POINT LABORATORIES LTD","customerCountry":"INDIA","quantity":"1.25","actualQuantity":"1.25","unit":"KGS","unitRateFc":"113000","totalValueFC":"141470","currency":"USD","unitRateINR":"9740600","date":"07-Jul-2025","totalValueINR":"12175750","totalValueInUsd":"141470","indian_port":"Madras Air","hs_no":"29420090","bill_no":"3101530","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"ZUOANMINGDI XIANSHUIGU JINNAN DISTRICT TIANJIN 300350 CN","customerAddress":"NARBAVI, NO.3,LAKSHMANAN STREET,"}]
25-Mar-2022
07-Jul-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more
  • Development Update

Details:

Undisclosed


Lead Product(s): Azole,Anidulafungin

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: ZonMw | Stichting Hemato-Oncologie voor Volwassenen Nederland

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 06, 2021

blank

01

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Country
arrow
World Drug Safety EU
Not Confirmed

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Country
arrow
World Drug Safety EU
Not Confirmed

Lead Product(s) : Azole,Anidulafungin

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : ZonMw | Stichting Hemato-Oncologie voor Volwassenen Nederland

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 06, 2021

blank
  • Development Update

Details:

Undisclosed


Lead Product(s): Anidulafungin,Inapplicable

Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 24, 2011

blank

02

Fundacion SEIMC-GESIDA

Country
arrow
World Drug Safety EU
Not Confirmed

Fundacion SEIMC-GESIDA

Country
arrow
World Drug Safety EU
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 24, 2011

blank

03

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 25, 2010

blank

04

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

August 05, 2010

blank
  • Development Update

Details:

Undisclosed


Lead Product(s): Anidulafungin,Inapplicable

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 22, 2010

blank

05

Elisabethinen Hospital

Country
arrow
World Drug Safety EU
Not Confirmed

Elisabethinen Hospital

Country
arrow
World Drug Safety EU
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

January 22, 2010

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Anidulafungin

Brand Name : Anidulafungin

Dosage Form : Injection

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Anidulafungin

Brand Name : Anidulafungin

Dosage Form : Injection

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

03

Accord healthcare

United Kingdom
World Drug Safety EU
Not Confirmed
arrow

Accord healthcare

United Kingdom
arrow
World Drug Safety EU
Not Confirmed

Anidulafunginum

Brand Name : Anidulafungin Accord

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Pfizer Inc

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

ANIDULAFUNGIN

Brand Name : ERAXIS

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 21948

Regulatory Info :

Registration Country : USA

blank

05

Pfizer Inc

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

anidulafungin

Brand Name : ECALTA

Dosage Form : POWDER FOR CONCENTRATE FOR

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

Pfizer Inc

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Anidulafungin

Brand Name : Ecalta

Dosage Form : Anidulafungina 100Mg 30Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 100 mg 30 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Pfizer Inc

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Anidulafunginum

Brand Name : Ecalta

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Pfizer Inc

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Anidulafungin

Brand Name : ERAXIS 100 mg

Dosage Form : INF

Dosage Strength : 100mg/30ml

Packaging : 30X1mg/30ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

09

Polifarma

Turkey
World Drug Safety EU
Not Confirmed
arrow

Polifarma

Turkey
arrow
World Drug Safety EU
Not Confirmed

Anidulafungin

Brand Name :

Dosage Form : Powder for Solution for IV Infusion

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

10

World Drug Safety EU
Not Confirmed
arrow
arrow
World Drug Safety EU
Not Confirmed

ANIDULAFUNGIN

Brand Name : CARIXAN

Dosage Form : INF

Dosage Strength : 100MG/30ML

Packaging : 30X1MG/30ML

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Accord Healthcare AG

United Kingdom
World Drug Safety EU
Not Confirmed
arrow

Accord Healthcare AG

United Kingdom
arrow
World Drug Safety EU
Not Confirmed

Anidulafunginum

Brand Name : Anidulafungin Accord

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Labatec Pharma SA

Switzerland
World Drug Safety EU
Not Confirmed
arrow

Labatec Pharma SA

Switzerland
arrow
World Drug Safety EU
Not Confirmed

Anidulafunginum

Brand Name : Anidulafungin Labatec

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Pfizer Ltd.

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Ltd.

U.S.A
arrow
World Drug Safety EU
Not Confirmed

anidulafungin

Brand Name : Ecalta

Dosage Form : POWDER AND SOLVENT FOR CONCENTRATE FOR

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

Pfizer Ltd.

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer Ltd.

U.S.A
arrow
World Drug Safety EU
Not Confirmed

anidulafungin

Brand Name : ECALTA

Dosage Form : POWDER FOR CONCENTRATE FOR

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

World Drug Safety EU
Not Confirmed
arrow
arrow
World Drug Safety EU
Not Confirmed

Anidulafungin

Brand Name : Ecalta

Dosage Form : Anidulafungina 100Mg 30Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 100 mg 30 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

World Drug Safety EU
Not Confirmed
arrow
arrow
World Drug Safety EU
Not Confirmed

Anidulafungin

Brand Name : Ecalta

Dosage Form : Powder to concentrate to the infusion fluid, resolution

Dosage Strength : 100 mg

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

Pfizer AG

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer AG

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Anidulafunginum

Brand Name : Anidulafungin Pfizer

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Pfizer AG

U.S.A
World Drug Safety EU
Not Confirmed
arrow

Pfizer AG

U.S.A
arrow
World Drug Safety EU
Not Confirmed

Anidulafunginum

Brand Name : Ecalta

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Solubilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Direct Compression

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Topical

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 166663-25-8 / Anidulafungin API manufacturers, exporters & distributors?

Anidulafungin manufacturers, exporters & distributors 1

52

PharmaCompass offers a list of Anidulafungin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Anidulafungin manufacturer or Anidulafungin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Anidulafungin manufacturer or Anidulafungin supplier.

PharmaCompass also assists you with knowing the Anidulafungin API Price utilized in the formulation of products. Anidulafungin API Price is not always fixed or binding as the Anidulafungin Price is obtained through a variety of data sources. The Anidulafungin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Anidulafungin

Synonyms

Eraxis, 166663-25-8, Ecalta, V-echinocandin, Ver-002, Ly303366

Cas Number

166663-25-8

Unique Ingredient Identifier (UNII)

9HLM53094I

About Anidulafungin

Echinocandin antifungal agent that is used in the treatment of CANDIDEMIA and CANDIDIASIS.

Anidulafungin Manufacturers

A Anidulafungin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anidulafungin, including repackagers and relabelers. The FDA regulates Anidulafungin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anidulafungin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Anidulafungin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Anidulafungin Suppliers

A Anidulafungin supplier is an individual or a company that provides Anidulafungin active pharmaceutical ingredient (API) or Anidulafungin finished formulations upon request. The Anidulafungin suppliers may include Anidulafungin API manufacturers, exporters, distributors and traders.

click here to find a list of Anidulafungin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Anidulafungin USDMF

A Anidulafungin DMF (Drug Master File) is a document detailing the whole manufacturing process of Anidulafungin active pharmaceutical ingredient (API) in detail. Different forms of Anidulafungin DMFs exist exist since differing nations have different regulations, such as Anidulafungin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Anidulafungin DMF submitted to regulatory agencies in the US is known as a USDMF. Anidulafungin USDMF includes data on Anidulafungin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Anidulafungin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Anidulafungin suppliers with USDMF on PharmaCompass.

Anidulafungin KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Anidulafungin Drug Master File in Korea (Anidulafungin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Anidulafungin. The MFDS reviews the Anidulafungin KDMF as part of the drug registration process and uses the information provided in the Anidulafungin KDMF to evaluate the safety and efficacy of the drug.

After submitting a Anidulafungin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Anidulafungin API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Anidulafungin suppliers with KDMF on PharmaCompass.

Anidulafungin WC

A Anidulafungin written confirmation (Anidulafungin WC) is an official document issued by a regulatory agency to a Anidulafungin manufacturer, verifying that the manufacturing facility of a Anidulafungin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Anidulafungin APIs or Anidulafungin finished pharmaceutical products to another nation, regulatory agencies frequently require a Anidulafungin WC (written confirmation) as part of the regulatory process.

click here to find a list of Anidulafungin suppliers with Written Confirmation (WC) on PharmaCompass.

Anidulafungin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anidulafungin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Anidulafungin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Anidulafungin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Anidulafungin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anidulafungin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Anidulafungin suppliers with NDC on PharmaCompass.

Anidulafungin GMP

Anidulafungin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Anidulafungin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anidulafungin GMP manufacturer or Anidulafungin GMP API supplier for your needs.

Anidulafungin CoA

A Anidulafungin CoA (Certificate of Analysis) is a formal document that attests to Anidulafungin's compliance with Anidulafungin specifications and serves as a tool for batch-level quality control.

Anidulafungin CoA mostly includes findings from lab analyses of a specific batch. For each Anidulafungin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Anidulafungin may be tested according to a variety of international standards, such as European Pharmacopoeia (Anidulafungin EP), Anidulafungin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anidulafungin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty